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Summary: Thirty six individuals with angiographic evidence of coronary atherosclerosis and thirty six individuals
without coronary disease, matched for a variety of cardiovascular risk factors including age, sex, smoking, hyperten-
sion, diabetes and family history, were evaluated for their serum concentrations of vitamin E, total cholesterol,
triacyglycerols, high density lipoprotein-cholesterol, low density lipoprotein-cholesterol, apolipoprotein A-I, and
apolipoprotein B. Apolipoprptein B, low density lipoprotein-cholesterol and total cholesterol concentrations were
unequivocally higher in patients with coronary artery disease. Triacylglycerols were marginally higher in patients
with disease. The antioxidant vitamin E (α-tocopherol) was significantly higher in patients with atherosclerosis
when compared with controls (35.1 ± 17.0 μηιοΙ/1 vs. 29.0 ± 13.2 μτηοΐ/l, p = 0.017). However, a-tocopherol
concentrations were strongly associated with lipid concentrations and normalization to the total cholesterol concen-
trations produced ratios which were not significantly different in the two groups. Logistic regression analysis
revealed that the association of lipid risk factors with coronary Stenosis was determined primarily by the difference
in total cholesterol values. This study demonstrated that in this group of patients referred for angiography and
matched for other risk factors, higher α-tocopherol concentrations were associated with patients with coronary
disease and were not usefiil for assessing risk of coronary artery disease.
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vvith regard to other, pertinent risk factors including age,
sex, family history of heart disease, hypertension and
smoking. In this manner, we hoped to emphasize the
relationship of the laboratory results to the presence or
absence of disease.
Materials and Methods
Patients
Three hundred and seventy seven patients referred to the Cleveland
Clinic Foundation for coronary angiography were considered for
the study. Patients participating in this study signed appropriate
informed consent approved by the Institutional Review Board. Cor-
onary artery disease was considered present if greater than 30% of
a major vessel was Stenosed and the final diagnosis was coronary
artery disease. Coronary artery disease was considered absent only
if there was no defmed Stenosis in all vessels. Of this group, 43
males were found to be free of disease and the remaining group of
positive patients was evaluated for optimal match of age, sex,
smoking history, hypertension, angina, diabetes mellitus, ECG ab-
normal ities, past myocardial infarction, and family history äs ob-·
tained from the medical record. As a result of this process and the
availability pf suffkient sample, 36 pairs of matched cases were
included förxstudy for a total of 72 individuals.
Sampling
Serum was obtained at the time of admission for cardiac catheteriz-
ation, aliquoted and stored frozen at —70 °C until time of analysis
except for total cholesterol, triacylglycerols and high density lipo-
protein-cholesterol which were determined the day of sample col-
lection. All patients had fasted for at least 12 hours before blood
sampling. Whenever possible, the number of separate analytical
runs was minimized.
Apolipoprotein assays
Apolipoprotein A-I and apolipoprotein B were measured with an
Array nephelometric protein analyzer (Beckman Instruments, Brea
CA) with reagents obtained from the manufacturer and according
to their instructions.
-Tocopherol assay
-Tocopherol was measured using reverse phase high performance
liquid chromatography. In brief, 0.5 ml of plasma is combined with
an equal volume of a solution of D-a-tocopherol acetate (internal
Standard), 25 mg/1 in ethanol, mixed, 1.0 ml of hexane is added,
the mixture vortexed for 45 seconds and centrifuged to separate
layers. The top layer is removed, evaporated to dryness under nitro-
gen at room temperature and reconstituted with 200 of mobile
phase. Chromatography was carried out using a C-l 8 reverse-phase
column (30 cm, Millipore Waters Bondapak, Milford CT) with a
C-l8 guard column. System components were all obtained from
Millipore Waters. The mobile phase consisted of methanol : water
(95 + 5, by vol.), flow rate was 2.5 ml/min and detection was ac-
complished by measurement of absorbance at 280 nm. Standar-
dization was efTected using a series of Standards prepared by dis-
solving defüned amounts of -tocopherol and internal Standard in
absolute ethanol and comparison of peak height ratios after chrom-
atography in the usual manner. Typical retention times were 2.35
min, 8.82 min and 10.88 min for retinol, -tocopherol and ct-toc-
opherol acetate respectively.
Lipid assays
Total cholesterol was determined enzymatically with reagents ob-
tained from Boehringer Manheim Diagnostics (Indianapolis, IN)
with a Hitachi 717 analyzer according to the manufacturer's proto-
col. This method was standardized to the National Cholesterol Ref-
erence Standard. Triacylglycerols were measured enzymatically
with reagents obtained frorn Boehringer; results were corrected for
the presence of free glycerol by use of lipase-free blank reagent.
High density lipoprotein cholesterol was measured using the dex~
trän sulfate (Mr 50 000) magnesium Chloride precipitation method
äs described elsewhere (3). Cholesterol in high density lipoprotein
subfractions were quantified according to the dextran sulfate-mag-
nesium Chloride method described elsewhere (4). Low density lipo-
protein and very low density lipoprotein- cholesterol concentrations
were calculated from the corresponding triacylglycerols, total chol·
esterol and high density lipoprotein-cholesterol concentrations us-
ing the Friede wald formal a if triacyglycerol välues were less than
4.57 mmol/1 (4000 mg/1).
Ultracentrifugation
If triacyglycerol välues exceeded 4.57 mmol/1, cholesterol in lipo-
protein fractions was estimäted by Ultracentrifugation according to
a Standard protocol (5). One ml of serum was added to 4.0 ml of
9.0 g/l sodium Chloride (density = 1.006 kg/l) containing 1.0 g/l
sodium ethylenediamine tetracetate in äe ulträcentrifuge tube. The
sample was ultracentrifuged for 15 hours at 16°C at 109074g
relative centrifugal force. The tube was subsequently placed in a
tube cutter and the top 1.5 ml fraction removed volumetrically with
a 2.0 ml plastic syringe followed by removal of the lower remain-
ing ftaction after mixing. Cholesterol in the fractions was deter-
mined äs described above the very low density and low density
lipoprotein-cholesterol concentrations derived after cprrection for
recovery.
Statistics
All data distributions were evaluated for normalcy using the Kol-
mogorov-Smirnov test and non-parametric methods used where ap-
propriate (6). The Mann-Whitney test for variance was used to com-
pare variables in the group with and without coronary artery dis^
ease (6). Probability välues of less than 0.05 were considered sig-
niflcant. Because very low density lipoprotein-cholesterol was
calculated from triacyglycerols in the majority of subjects, this va-
riable was considered dependent on triacyglycerols and was not
treated separately. Spearman correlation coefficients were calcu-
lated (6). Associations amongst variables were assessed with step-
wise multivariate linear regression (6). Association of signifieant
variables with the presence or absence of coronary artery disease
was investigated with stepwise logistic regression (7). All statistical
analyses were conducted using SYSTAT Software (Evanston, IL)
except for logistic regression which was performed using BMDP
Software (Berkeley, CA).
Results
The thirty six matched cases used in this study included
10 of 36 with confirmed angina, 31 of 36 with ECG
changes, 14 of 36 with hypertension, 4 of 36 diabetes, l
of 36 with history of myocardial infarction and 8 of 36
who were currently smoking. Eighteen of 36 padred
cases were age matched within one year, 13 of 36 were
within 2—5 years and 5 of 36 were within 6—8 years.
The average age of the group without coronary artery
disease was 50.0 ± 6.0 years and the average age of
the group with disease was 51.0 ± 5.5 years and this
difference was not significant. The average body mass
index [defined äs weight *(kg): height (m^); välues
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greater than 30 indicate obesity] was similar in both
groups (27.9 ± 4.4 kg/m2, 28.1 ± 3.7 kg/m2, p = 0.66,
Mann-Whitney test). All subjects were males. Specific
dietary histories were not available for these subjects but
there was no evidence in the medical record that any
subject was prescribed or was following a low-fat diet
or had unusual dietary habits. None of the subjects were
taking vitamin E or selenium Supplements and two were
taking vitamin C Supplements.
Table l lists the average analyte values found in the
group without abnormalities on angiography and deter-
mined to have normal coronary arteries compared with
the group with atherosclerosis. The components assayed
are listed in decreasing order of significance s deter-
mined by the Mann-Whitney test. High density lipo-
protein-2 exhibited slightly higher values in patients
without coronary artery disease (0.176 ±0.173 mmol/1)
than in those with coronary artery disease (0.137
±0.121 mmol/1), but this difference was not significant
(p = 0.37, Mann-Whitney test). Similar fmdings were
observed for high density lipoprotein-3 (0.778 ±0.132
vs. 0.747 ±0.150 mmol/1, p = 0.41). The mass ratios
of high density lipoprotein-cholesterol and apolipo-
protein A-I to apolipoprotein B did not reveal differ-
ences between groups greater than those shown in table
l for ratio components. In most cases, the differences
were less significant.
Apolipoprotein-B and low density lipoprotein-choles-
terol were significantly higher in patients with coronary
artery disease, a fmding consistent with most other stud-
ies, but vitamin E, generally considered a protectant,
was significantly higher in this group s well. To explore
this finding further, the correlations between the antioxi-
dants α-tocopherol and the remaining analytes were de-
termined and these are shown iii table 2. Significant cor-
relati ns were obtained between α-tocopherol and total
cholesterol, triacyglycerols and the cholesterol fractions.
Stepwise multivariate linear regressi n nalysis revealed
that the strongest association of those listed was between
Tab. 2 Correlation of α-tocopherol with other analytes.
Analyte Correlation
coefficient
Cholesterol
Triacyglycerols
HDL-cholesterol
LDL-cholesterol
Apolipoprotein B
Apolipoprotein A-I
0.55*
0.64*
-0.41*
0.41*
0.54*
-0.22
0.01
α-tocopherol and low density lipoprotein-cholesterol
with a multivariate R = 0.489. The resultant linear re-
gressi n equation was α-tocopherol = 0.002 (TRIG)
+ 0.005 (LDL) + 0.317.
Due to the strong association of lipophilic α-tocopherol
with lipoprotein particles, it has been suggested that it
is more appropriate to express α-tocopherol concen-
trations in plasma s a ratio to lipoprotein content (1).
When mass ratios were calculated using α-tocopherol
and total cholesterol concentrations, the average ratio
was not significantly different (p = 0.14) in patients
without coronary artery disease (6.2 ± 2.9) compared
with those with coronary artery disease (6.6 ± 2.7). The
mass ratios of α-tocopherol to triacyglycerols were not
significant different (8.5 ± 5.1 vs. 7.8 ± 4.1, p = 0.66)
s were the ratios of α-tocopherol to low density lipo-
protein-cholesterol (9.3 ± 4.3 vs. 9.8 ± 4.8, p = 0.53).
Normalization of α-toeopherol concentrations to apo-
lipoprotein concentrations also did not reveal any sig-
nificant differences between groups.
Logistic regressi n nalysis was performed in a stepwise
manner to further assess the association of the risk fac-
tors listed in table 3 with the presence of coronary artery
disease. Total cholesterol demonstrated the strongest as-
sociation with atherosclerosis, followed by triacyglycer-
ols, low density lipoprotein-cholesterol, and α-tocophe-
rol. Apolipoprotein B demonstrated a weaker associ-
Tab. l Cornparison of average (Standard deviatiqn) analyte values in patients with and without coronary artery disease.
No.
Subjects
Apolipoprotein B
LDL-cholesterol
a-Toc pherol
Cholesterol
Triacyglycerols
HDL-cholesterol
Apolipoprotein A-I
^ Coronary artery disease
mg/1
mmol/1
jimol/l
mmol/1
mmol/I
mmol/1
mg/1
absent
36
956
3.65
29.0
5.34
2.05
0.95
1151
(306)
(1.00)
(13.2)
(i.ii)
(1.12)
(0.28)
(195)
present
36
1080
4.15
35.1
5.96
2,96
0.87
1126
(254)
(1.02)
(17.0)
(1.16)
(2.12)
(0.19)
(171)
P*
0.010
0.017
0.017
0.033
0.097
0.261
0.700
Mann-Whitney Test
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Tab. 3 Logistic regression analysis of laboratory-derived risk
factors.
Analyte
Cholesterol
Triacylglycerols
LDL-cholesterol
a-Tocopherol
Apolipoprotein B
Log"
likelihood
-47.29
-47.32
-47.69
-48.47
-48.95
P°
value
0.022
0.028
0.035
0.090
0.167
Pb
value
0.022
0.144
0.777
0.400
0.493
a
 First step with only the constant term included in model
b
 Second step with cholesterol included in model
ation. However, when cholesterol was included in the
categorical regression model äs a predictor, the indepen-
dent association of the other risk factors was diminished
to insignificance. Therefore, the association of these fac-
tors with atherosclerosis in this study group is accounted
for by the difference in total cholesterol.
Discussion
The majority of patients who underwent angiography in-
cluded in this study were referred for catheterization due
to either possible cardiac-related ehest pain or abnormal
electrocardiograms. The usual lipid values, total choles-
terol and triacylglycerols, were known to the referring
physician and were usually noted in the review of medi-
cal history at the time of angioplasty. Therefore, a subtle
selection bias relative to these analyte concentrations
cannot be totally ruled out although the average total
cholesterol value found in patients without angiography
evidence of Stenosis was lower than a mean of 5.75
± 1.77 mmol/1 observed in 5800 male outpatients seen
at our facility for health assessment. It is of interest that
the average high density lipoprotein-cholesterol value in
patients without coronary disease was relatively low,
even when compared with our own mean for 5800 male
outpatients (1.13 ±0.31 mmol/1). The significance of
this finding remains unclear. High density lipoprotein-
cholesterol was without exception not referenced in the
review of patient history and reasons for referral, so al-
though selection bias cannot be ruled out, there is no
compelling evidence that it was present with respect to
decreased high density lipoprotein-cholesterol values.
All patients with hypertension and on medication were
case-controlled such that the Overall effect of drugs such
äs beta-blockers known to lower high density lipo-
protein should be minimal.
-Tocopherol demonstrated a clear significant difference
between groups. The difference in -tocopherol concen-
tration is likely due to its association with lipoproteins,
äs evidenced by the correlations shown in table 2. This°
leads to significantly higher -tocopherol concentrations
in individuals with higher average lipid concentrations,
a somewhat counterintuitive finding. Normalization of
-tocopherol concentrations to cholesterol, in particular,
eliminäted the significance of the difference between
groups, although this ratio tended to be higher in
patients without coronary Stenosis. A higher ratio of vit-
amin E to low density lipoprotein-cholesterol, expressed
variously on a massrto^molar basis, or a mass-to-mass
basis or on a molar-to-molar basis had been suggested
to reduce risk of coronary atherosclerosis regardless of
cholesterol concentrations (l, 8). This ratio can also be
expressed in terms of apolipoprotein B or lipoprotein
protein content. However, We did not observe an in-
creased significance in average values between groups
when -tocopherol was expressed äs a ratio to apolipo-
protein B rather than to low density lipoprotein-choles-
terol.
-Tocopherol is, on a molar basis, the major antioxidant
associated with low density lipoprotein (1). Other anti-
oxidants such äs carotenoids, ubiquinol-10 and hydro·?
philic antioxidants such äs ascorbic acid are present at
much lower concentrations (1). However, the presence
of a given concentration of an antioxidant such äs a-
tocopherol may not accurately reflect the antirpro^oxi-
dant Status of a lipoprotein particle. The dynamic inter-
actions occurring amöngst lipoproteins, their constitu^
ents and the remaining antioxidants and prooxidants in
•the circulation are likely to be very coniplex. In vitro,
-tocopherol associated with low density lipoprotein has
been shown to exchange intermolecularly with estimated
half-lifes of 20-70 min (9). This study did not attempt
to assess the associated lipid peröxide coneentrations al-
though this determination may aid in the Identification
. of excess oxidative modification of low density lipo-
protein in patients with coronary artery disease.
It is important to note that the association of vitamin E
with reduced risk of cardiac disease is strengthened by
supplementation of the usual dietary iratake (10). In ad-
dition, there is evidence that this supplementation must
exceed a threshold before protective effects are ächieved
(l, 11). The data obtained here on a group of men not
taking vitamin E Supplements suppoft this nötation by
failing to exhibit significantly higher -tocopherol con-
centrations or ratios to lipid concentrations in the ab-
sence of coronary artery disease. We could not ascertain
the effect of dietary vitamin E on this association and,
thus, it cannot be ruled out. The confirmation of the
Utility of measurement of this antioxidant in serum or
plasma will probably require further prospective evalu-
ation of patients receiving significant vitamin E sup-
plementation, in a diet-controlled Situation.
In conclusion, this study dempnstrates that a-tocöpherol
concentrations may be aetually increased in patients
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with coronary artery disease due to its association with
increased concentrations of lipoproteins. This study also
confirmed the relevance of an increased total cholesterol
concentration to the presence of coronary artery disease
when other clinical factors are controlled. Apolipo-
protein B and low density lipoprotein-cholesterol were
also increased significantly in patients with coronary ar-
tery disease. The remaining risk factors analyzed did not
achieve significance and their relevance could not be
validated. Expressing vitamin E äs a mass ratio elimin-
ated the significance of the difference observed between
groups. Therefore, although oxidative modification of
low density lipoprotein may be important in the devel-
opment of atheroslcerosis the measurement of total a-
tocopherol in serum does not provide useful Information
regarding its potential role äs a preventive antioxidant.
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